Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. - Smulevich,AB.; Khanna,S. (Eur Neuropsychopharmacol, 2005)